跳至主要内容
临床试验/NCT01373034
NCT01373034Unknown不适用

The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome: Double-blind, Randomized, Placebo-controlled, Cross Over Clinical Trial

Seoul National University Hospital2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
36
试验地点
2
主要终点
sum of irritable bowel syndrome symptom score

研究概览

简要总结

The investigators will evaluate the efficacy of soy dietary fiber in adults with diarrhea predominant irritable bowel syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • willing to consent/undergo necessary procedures
  • between the age of 19 and 75 years
  • diarrhea predominant irritable bowel syndrome (satisfied with Rome II criteria)

排除标准

  • uncontrolled hypertension (Blood pressure > 170/100 mmHg)
  • uncontrolled diabetes mellitus (FBS > 180 mg/dL)
  • malignancy, cerebrovascular disease, cardiovascular disease
  • history of abdominal surgery except appendectomy and hernia repair
  • inflammatory bowel disease
  • clinically or laboratory-confirmed gastroenteritis
  • the use of motility drug or dietary fiber supplement in 2 weeks
  • allergy to soy fiber
  • serum Cr > 2 x Upper normal limit
  • AST or ALT > 2 x Upper normal limit
  • Pregnancy, Lactating woman

结局指标

主要结局

sum of irritable bowel syndrome symptom score

时间窗: after 4 weeks

abdominal pain / abdominal discomfort urgency tenesmus abdominal distension

次要结局

  • irritable bowel syndrome symptom score(after 2 weeks and 4 weeks)
  • Stool frequency and form(after 2 weeks and 4 weeks)
  • Symptom control of irritable bowel syndrome(after 2 weeks and 4 weeks)
  • Improvement of overall symptom in patient with irritable bowel syndrome(after 2 weeks and 4 weeks)
  • Severity of overall symptom in patient with irritable bowel syndrome(after 2 weeks and 4 weeks)
  • Severity of diarrhea(after 2 weeks and 4 weeks)
  • Assessment for quality of life related with irritable bowel syndrome(after 2 weeks and 4 weeks)
  • Assessment for patient satisfaction after administration completion(after 2 weeks and 4 weeks)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验